Revolution Medicines(RVMD) - 2023 Q1 - Earnings Call Transcript

Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Erin Graves - Senior Director of Corporate Communications and Investor Relations Mark Goldsmith - Chairman, President & Chief Executive Officer Steve Kelsey - President of Research & Development Jack Anders - Chief Financial Officer Conference Call Participants Marc Frahm - TD Cowen Eric Joseph - JPMorgan Chase & Co. Michael Schmidt - Guggenheim Partners Benjamin Burnett - Stifel Jay Olson ...